Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosi

NCT05518305 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05518305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05518305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosi
Lead sponsor
University of California, Los Angeles
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2022
Completion date
September 30, 2027
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic, ischemic stroke, stroke, tia